Chapter 7 — Key Takeaways
What you should leave Chapter 7 with
-
Stereoisomers have identical connectivity (same atoms bonded to the same atoms) but different 3D arrangements. Two types: enantiomers (mirror images) and diastereomers (not mirror images).
-
Constitutional isomers vs stereoisomers: constitutional isomers have different connectivity; stereoisomers have the same connectivity in different 3D arrangements.
-
Conformational isomers (rotamers) are NOT stereoisomers — they interconvert by rotation around single bonds. Stereoisomers cannot be interconverted by rotation alone.
-
Chiral center (stereocenter): sp³ carbon with four different substituents. Primary source of stereoisomerism in most organic molecules.
-
Other sources of chirality: - Atropisomerism: hindered rotation around a single bond gives stable enantiomers (e.g., 1,1'-binaphthyl). - Axial chirality: allenes (R₂C=C=CR'₂) have perpendicular ends giving chirality. - Planar chirality: certain stacked systems (cyclophanes, ferrocenes). - Helical chirality: helices (DNA, helicenes) have inherent handedness.
-
CIP (Cahn-Ingold-Prelog) priority rules assign R/S to stereocenters: - Rule 1: Higher atomic number = higher priority at first point of difference. - Rule 2: Heavier isotope = higher priority. - Rule 3: At ties, move outward and compare the next-shell atoms. - Rule 4: Multiple bonds counted as duplicate atoms. - Procedure: orient lowest-priority group back; trace 1→2→3 clockwise = R, counterclockwise = S.
-
R/S vs (+)/(−) are independent: - R/S is a structural label (stereochemistry assignment). - (+)/(−) is an experimental measurement (optical rotation). - A single compound can be (R,+) or (R,-) — no fixed correlation.
-
Meso compounds have stereocenters but an internal mirror plane makes them achiral overall. Example: meso tartaric acid (2R,3S = 2S,3R).
-
Enantiomers: - Mirror images, non-superimposable. - Identical physical properties in achiral environment (mp, bp, NMR, IR). - Different: optical rotation (equal magnitude, opposite sign) and interactions with other chiral things (receptors, catalysts). - Cannot be separated by ordinary means; require chiral environment.
-
Diastereomers:
- Stereoisomers that are NOT mirror images.
- Different physical properties (mp, bp, IR, NMR).
- Separable by ordinary means (chromatography, crystallization, distillation).
-
n stereocenters → up to $2^n$ stereoisomers. Some may be meso, reducing the count. Tartaric acid: $2^2 = 4$ max, but actual = 3 (one meso pair).
-
Optical activity: enantiomers rotate plane-polarized light equally and oppositely. Specific rotation $[\alpha]_D$ is the standardized measure (normalized for concentration and path length).
-
Racemic mixture: 50:50 of two enantiomers; zero optical rotation.
-
Enantiomeric excess (ee): |%major − %minor|. Measured today by chiral HPLC (more reliable than optical rotation).
-
Fischer projections: 2D representation of stereocenters with horizontal bonds = toward viewer, vertical = away. Standard for sugars and amino acids.
-
D/L convention (older system, still used for biomolecules):
- D-sugars, L-amino acids are nature's choices.
- L = (S) for most amino acids (cysteine is the exception due to CIP priority quirk).
- D vs L is by Fischer projection orientation, not by optical rotation.
-
Alkene geometry (E/Z): at C=C, if the two CIP-higher-priority groups are on the same side: Z; opposite sides: E.
-
Resolution methods for separating enantiomers:
- Diastereomer formation with chiral resolving agent (Pasteur's classical method).
- Chiral chromatography (HPLC with chiral stationary phase).
- Asymmetric synthesis (avoid racemate altogether using chiral catalysts).
- Kinetic resolution (chiral catalyst reacts faster with one enantiomer).
-
Biological consequences are huge:
- Receptors built from L-amino acids are chiral.
- Enantiomers of drugs typically have different activities (one active, one inactive or harmful).
- Examples: thalidomide, ibuprofen, naproxen, omeprazole, salbutamol, methorphan.
- FDA recommends developing drugs as single enantiomers.
-
Asymmetric synthesis (Nobel 2001 to Knowles, Noyori, Sharpless) is now routine in pharmaceutical chemistry. Industrial drugs made by asymmetric methods include L-DOPA, naproxen, atorvastatin, sitagliptin, esomeprazole, and many others.
-
Mastery of Chapter 7 is the foundation for:
- Understanding stereochemistry in reactions (Ch 8).
- Reading NMR (Ch 9) — coupling constants depend on stereochemistry.
- Predicting SN/E products (Chs 10-13).
- Understanding addition stereochemistry (Chs 15-17).
- Carbohydrate chemistry (Ch 32).
- Protein structure (Ch 33).
- Drug design (Ch 35).
- Asymmetric synthesis (Ch 36, 37).
Cross-references
- Chapter 2 — Bonding (sp³ tetrahedral geometry foundation).
- Chapter 5 — Conformations (vs stereoisomers).
- Chapter 8 — Stereochemistry in reactions.
- Chapter 9 — NMR (coupling constants depend on dihedral angles).
- Chapter 10-14 — SN/E (stereochemistry of substitution and elimination).
- Chapter 15-17 — Addition reactions (cis/trans products).
- Chapter 32 — Carbohydrates (D/L conventions; epimers; anomers).
- Chapter 33 — Amino acids (L-only).
- Chapter 35 — Drug design (chirality and pharmacology).
- Chapter 36 — Asymmetric oxidation and reduction.
- Chapter 37 — Asymmetric organometallic catalysis.
- Appendix C — Reaction summary.
Study tip
For every chiral molecule you encounter: 1. Identify stereocenters (count them). 2. Determine maximum number of stereoisomers ($2^n$). 3. Check for meso compounds (look for internal mirror plane). 4. Assign R/S to each stereocenter using CIP. 5. Predict interactions with chiral environments (receptors, catalysts).
For drug examples: which enantiomer is active? Which is inactive or harmful? Why does this matter?
The habit to leave with: Look at any chiral molecule and say "this is the (R)-form" or "this is the (S)-form" or "this has 2 stereocenters and 4 possible stereoisomers, including 1 meso." Make the analysis automatic. Stereochemistry is not optional in modern organic chemistry — it's the language of biology, pharmacology, and asymmetric synthesis.
Chapter 8: stereochemistry in reactions — what happens to a stereocenter when a bond breaks and forms.